Comparison of the Clinical Efficacy and Adverse Reactions of Different Needling Patterns of High-frequency Microneedles in the Treatment of Axillary Odor
1 other identifier
interventional
90
1 country
1
Brief Summary
- Background: Axillary osmidrosis is a common skin disease characterized by an unpleasant odor produced when secretions from apocrine sweat glands in the armpits are decomposed by bacteria on the skin. It affects people's social interactions and psychology. Gold microneedle is a method for treating axillary osmidrosis, which achieves the therapeutic purpose by destroying the glands through radiofrequency heating. However, it remains unknown whether different movement patterns have an impact on the therapeutic effect and adverse reactions.
- Purpose and expected outcomes: This study intends to prospectively collect patients with axillary osmidrosis who visit our hospital, randomly divide them into the horizontal row movement, vertical row movement and mixed movement pattern groups, evaluate the efficacy and occurrence of adverse reactions, and further understand the impact of different microneedle movement patterns on the treatment of axillary osmidrosis.
- Design and methods: Patients who visit our hospital and are willing to receive gold microneedle treatment will be randomly divided into the horizontal row movement, vertical row movement and mixed movement pattern groups. A disposable sterile gold microneedle treatment head will be installed, and different parameters will be set according to the elasticity of the patient's underarm skin and the thickness of subcutaneous fat. The entire radiofrequency treatment area will be covered using horizontal row movement, vertical row movement and mixed movement patterns respectively. All three groups will be closely followed up after the operation; during each follow-up, patients will be required to perform the same exercise load as before the operation to evaluate the therapeutic effect and recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 30, 2025
CompletedJuly 30, 2025
July 1, 2025
1.5 years
July 23, 2025
July 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
cure rate
6 months
Secondary Outcomes (2)
effective rate
6 months
recurrece rate
6 months
Study Arms (3)
transverse needling group
EXPERIMENTALreceived transverse needling
vertical needling group
EXPERIMENTALreceived vertical needling
mixed needling group
EXPERIMENTALreceived mixed needling
Interventions
received transverse needling of high-frequency microneedles
received vertical needling of high-frequency microneedles
received mixed needling of high-frequency microneedles
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the First Affiliated Hospital of Chongqing Medical Uiversity
Chongqing, Chongqing Municipality, 400016, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician of Dermatology
Study Record Dates
First Submitted
July 23, 2025
First Posted
July 30, 2025
Study Start
October 18, 2023
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
July 30, 2025
Record last verified: 2025-07